PG-102
Asset
Activates GLP-1 and GLP-2 receptors through a bispecific Fc fusion protein to improve glycemic control.
- Stage
- Phase 2
- Modality
- Other
- Target
- GLP1R
- 1
- Indication
- 1
- Trial
- 1
- Developer
Indications
1Type 2 diabetes
Phase 2, doi.org, 5 Jun 2026
In the full profile
- Targets and what it contains2
- Owner and partners1
- Trials1
- Evidence for its targets3
- Competitors12
- Signals3
Every asset’s record: target, stage, trials and the evidence behind it.